Founded in August 2022, Moonlight AI is specialising in haematology & cytology. Aiming for a market launch in 2024-25, Moonlight AI's genomic biomarker and diagnosis solutions promise to revolutionize cancer diagnostics by addressing significant gaps in molecular testing for accurate patient care.
- http://www.moonlight-ai.com
- +41 79 539 25 62
- info@moonlight-ai.com
- Sezai Taskin, CEO
Some insights
The team excels in strategic development, machine learning, and clinical research, with expertise in launching precision medicines, leading international AI teams, securing significant research grants, and managing a large pathology lab. We aim to integrate further AI expertise into the team.